The team lead by Sílvia Vilares Conde, from CEDOC-NOVA Medical School, in collaboration with the pharmaceutical company Galvani Bioelectronics, demonstrated through findings in rats that is possible to restore insulin sensitivity and glucose homeostasis, by modulating electrically the carotid sinus nerve, the sensitive nerve that connects the carotid body with the brain.
The study is published in Diabetologia, the journal of the European Association for the Study of Diabetes [EASD].
In 2013, Silvia Vilares Conde and her research group described that the carotid body, a paired organ that is located in the bifurcation of the common carotid artery and that is classically defined as an oxygen sensor, regulates peripheral insulin sensitivity and that its dysfunction is involved in the development of metabolic diseases.
This first study and others afterwards performed by her group in diabetic rats showed that the bilateral resection of the carotid sinus nerve, and therefore the abolishment of the connection between the carotid body and the brain, restore insulin sensitivity and glucose tolerance. Although efficient this surgical irreversible approach has disadvantages, since the carotid body possess other physiological functions as the response to the lack of oxygen (hypoxia) or the adaptation to exercise. Silvia Conde’s team also described that the carotid body is over-activated in animal models of type 2 diabetes, suggesting that decreasing the activity of the organ could be a good therapeutic strategy.
From the partnership with Galvani Bioelectronics (former Glaxo Smith Kline Bioelectronics), the opportunity to electrically modulate the carotid sinus nerve come up. In fact, this work demonstrated that is possible to maintain glucose homeostasis in animals in which electrodes have been implanted in the carotid sinus nerve and submitted to electrical modulation, without significant adverse effects. It has also been demonstrated that the electrical modulation is reversible. Silvia Conde notes that “this work opens the door to the development of a new therapeutic for type 2 diabetes that will provide a long-term management of the disease with negligible adverse effects and interference with daily activities”.
Type 2 diabetes is characterized by insulin resistance and by increased hepatic glucose production that culminates in hyperglycemia. Although a lot of efforts have been performed until the date none therapeutic induce long-term glycaemia control, being expected for the next decades a huge increase in the prevalence of the disease. Thus, this work gives hope to patients with metabolic diseases, as it brings a new approach for the management of type 2 diabetes.
The Latest on: Type 2 diabetes
- Microalbuminuria Is Associated With Early Retinal Neurodegeneration in Patients With Type 2 Diabetes on September 18, 2018 at 1:39 pm
To evaluate retinal layer changes in patients with type 2 diabetes, microalbuminuria, and no diabetic retinopathy, and to investigate its possible relationship with age, gender, diabetes duration, uri... […]
- 21-year-old woman goes blind from type 2 diabetes complications on September 18, 2018 at 12:34 pm
A woman who went blind aged 21 is just one of many young type 2 diabetics experiencing serious complications due to poor management of the condition. University of Auckland associate professor in medi... […]
- Patient Voices Winner Dishes on T2 Diabetes Discrimination, Pregnancy and Drug Side Effects on September 18, 2018 at 9:16 am
Today, in the latest in our series of interviews with our 2018 DiabetesMine Patient Voices Contest winners, we're talking with type 2 advocate Cindy Campaniello in New York. After being diagnosed with ... […]
- The Rock's Lee Weir shares emotional battle against type 2 diabetes on September 18, 2018 at 5:50 am
Type 2 diabetes is the fastest growing chronic disease in the world. Around 250,000 New Zealanders have a diabetes diagnosis, and another 100,000 have it but don't know it yet. Until a few months ago, ... […]
- Does Sugar Cause Diabetes? Fact vs Fiction on September 18, 2018 at 4:12 am
There are two main types of diabetes, each with different causes: Type 1: Occurs when your immune system attacks your pancreas, destroying its ability to produce insulin. Type 2: Occurs when your panc... […]
- Study reveals the current rates of diagnosed type 1 and type 2 diabetes in American adults on September 17, 2018 at 11:20 pm
A new study from the University of Iowa finds that type 2 diabetes remains overwhelmingly the most common type of diabetes diagnosed in American adults who have the disease. The study found that 8 ... […]
- Study reveals prevalence of diagnosed type 1 and type 2 diabetes among American adults on September 17, 2018 at 10:39 pm
A new study from the University of Iowa finds that type 2 diabetes remains overwhelmingly the most common type of diabetes diagnosed in American adults who have the disease. The study found that 8.5 p... […]
- These Companies Want to Combine Stem Cells and CRISPR Gene Editing to Treat Diabetes on September 17, 2018 at 8:12 pm
Type 1 diabetes is a different beast from the type 2 variety that often soaks up the public health media spotlight. The disorder tends to afflict the young, and it’s caused by a defect in the ... […]
- 5 Awesome Diabetes Superfood You Should Eat on September 17, 2018 at 11:46 am
Diabetes is a health condition which the sugar/glucose levels build up in the bloodstream. Insulin hormone assists move the sugar from the blood into your cells which is where the sugar is used for en... […]
- Lose Weight, Reverse Type 2 Diabetes: Why It Works on September 17, 2018 at 9:37 am
Type 2 diabetes is caused by excess fat in the digestive organs, says an English researcher and physician who has seen his patients go into remission. Losing a substantial amount of weight can ... […]
via Google News and Bing News